CD14+ cell-derived IL-29 modulates proinflammatory cytokine production in patients with allergic airway inflammation
CD14+ cell-derived IL-29 modulates proinflammatory cytokine production in patients with allergic airway inflammation
复制标题
DOI:
10.1111/j.1398-9995.2010.02455.x
复制
发表时间:
2011-02-01
期刊:
影响因子:
12.4
通讯作者:
Yang, P.
中科院分区:
文献类型:
--
作者:
He, S.;Li, T.;Yang, P.
P>Background:Interleukin (IL)-29 is a newly described cytokine that has anti-viral activity, induces tumor cell death and regulates immune function. Whether it plays a role in immune disorders is unclear. This study aims to examine the role of IL-29 in the modulation of immune response under allergic environment.Methods:A group of patients with allergic asthma or/and allergic rhinitis was recruited to this study. Serum samples were collected from the patients in both in-season and out-season; the serum levels of IL-29 were determined by enzyme-linked immunoassay. Cell types of IL-29-producing cells in upper airway mucosa were identified with immune staining and examined by immunohistochemistry and flow cytometry.Results:High serum levels of IL-29 were detected in patients with allergic asthma in in-season, but not in out-season. The majority of IL-29+ cells in upper airway tissue were CD14+ cells. Exposure to specific antigens triggered the release of IL-4 from antigen-specific CD4+ T cells; the released IL-4 activated CD14+ cells to release IL-29; the released IL-29 further triggered the release of IL-6 and tumor necrosis factor from CD4+ T cells.Conclusions:Interleukin-29 is involved in the pathogenesis of allergic inflammation via modulating immune cells' function to release proinflammatory cytokines.